Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients

In this study we will assess as a primary objective the effect of venlafaxine retard treatment on primary care attended elderly patients with depressive syndrome. We will also study secondarily its effects on anxiety, somatic and painful symptoms of depression.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depressive Syndrome Anxiety Anxiety Disorders Behavior Behavioral Symptoms Depression Depressive Disorder Mental Disorders Mood Disorders

Age range

60 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients older than 60 years
Depressive syndrome with associated anxiety symptoms, according to a symptoms intensity HAM-D17³14

Exclusion criteria

Participation in other studies in the last 3 months before the start of the study
Known hypersensibility to venlafaxine
Clinically significant abnormalities according to the venlafaxine labeling

Sponsors and collaborators

Lead sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Industry

Registry information

Official study title

Vandral Retard (Venlafaxine Extended Release) in Depressive Syndrome With Anxiety and Painful Symptoms in Elderly Patients. Observational Study in Primary Care

Important dates

Study start: 2004
Primary completion: 2005
Study completion: 2005
First posted: Nov 1, 2005
Registry last updated: Sep 1, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting